Literature DB >> 29508044

Bladder wall injection of mesenchymal stem cells ameliorates bladder inflammation, overactivity, and nociception in a chemically induced interstitial cystitis-like rat model.

Akira Furuta1, Tokunori Yamamoto2, Taro Igarashi3, Yasuyuki Suzuki4, Shin Egawa3, Naoki Yoshimura5.   

Abstract

INTRODUCTION AND HYPOTHESIS: We investigated the effects of bladder wall injection of mesenchymal stem cells (MSCs) on bladder tissues, function, and nociceptive behavior in a chemically induced interstitial cystitis-like rat model.
METHODS: Chemical cystitis of female rats was induced by intravesical instillation of 0.1 N hydrochloride (HCl) once a week for 2 weeks. Bladders were harvested 1, 2, 3, and 4 weeks after the second application for histological examination. Adipose-derived MSCs (HCl + MSCs) or phosphate-buffered saline (HCl + PBS) was injected into the bladder wall at the time of the second application of HCl. Histological examination, nociceptive behavior, and cystometrograms were evaluated 2 weeks after the injection compared with controls, which received instillation and injection of PBS into the bladder (sham + PBS).
RESULTS: The number of mast cells and expression of tumor necrosis factor-α (TNF-α) and transforming growth factor-β (TGF-β) were significantly increased at 1 and 2 weeks, and expression of collagen fibers was significantly increased from 2-4 weeks after the second application of HCl. Significantly increased nociceptive behavior, number of mast cells, expression of TNF-α, TGF-β, and collagen fibers were observed in HCl + PBS compared with sham + PBS, whereas these changes were significantly decreased in HCl + MSCs compared with HCl + PBS. In addition, bladder capacity and voiding threshold pressures were significantly decreased in HCl + PBS but not in HCl + MSCs compared with sham + PBS.
CONCLUSIONS: The results suggest that bladder injection of MSCs ameliorates inflammation and fibrosis in bladder tissues, bladder overactivity, and nociception in a rat model of chemically induced cystitis.

Entities:  

Keywords:  Adipose; Hydrochloride; Interstitial cystitis; Mesenchymal stem cells; Rats

Mesh:

Substances:

Year:  2018        PMID: 29508044     DOI: 10.1007/s00192-018-3592-8

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  27 in total

Review 1.  In vivo models of interstitial cystitis.

Authors:  Jodi L Westropp; C A Tony Buffington
Journal:  J Urol       Date:  2002-02       Impact factor: 7.450

2.  Effects of isolectin B4-conjugated saporin, a targeting cytotoxin, on bladder overactivity induced by bladder irritation.

Authors:  Jun Nishiguchi; Katsumi Sasaki; Satoshi Seki; Michael B Chancellor; Kristin A Erickson; William C de Groat; Hiromi Kumon; Naoki Yoshimura
Journal:  Eur J Neurosci       Date:  2004-07       Impact factor: 3.386

3.  Bone marrow stromal cells generate muscle cells and repair muscle degeneration.

Authors:  Mari Dezawa; Hiroto Ishikawa; Yutaka Itokazu; Tomoyuki Yoshihara; Mikio Hoshino; Shin-ichi Takeda; Chizuka Ide; Yo-ichi Nabeshima
Journal:  Science       Date:  2005-07-08       Impact factor: 47.728

4.  Injection of Dental Pulp Stem Cells Promotes Healing of Damaged Bladder Tissue in a Rat Model of Chemically Induced Cystitis.

Authors:  Yujiro Hirose; Tokunori Yamamoto; Misako Nakashima; Yasuhito Funahashi; Yoshihisa Matsukawa; Masaya Yamaguchi; Shigetada Kawabata; Momokazu Gotoh
Journal:  Cell Transplant       Date:  2015-09-21       Impact factor: 4.064

5.  Cyclophosphamide cystitis in rats: involvement of capsaicin-sensitive primary afferents.

Authors:  C A Maggi; A Lecci; P Santicioli; E Del Bianco; S Giuliani
Journal:  J Auton Nerv Syst       Date:  1992-05-15

6.  Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness.

Authors:  Shaul Beyth; Zipora Borovsky; Dror Mevorach; Meir Liebergall; Zulma Gazit; Hadi Aslan; Eithan Galun; Jacob Rachmilewitz
Journal:  Blood       Date:  2004-10-28       Impact factor: 22.113

7.  Muscle regeneration by bone marrow-derived myogenic progenitors.

Authors:  G Ferrari; G Cusella-De Angelis; M Coletta; E Paolucci; A Stornaiuolo; G Cossu; F Mavilio
Journal:  Science       Date:  1998-03-06       Impact factor: 47.728

8.  Comparison of voiding function and nociceptive behavior in two rat models of cystitis induced by cyclophosphamide or acetone.

Authors:  Chikashi Saitoh; Hitoshi Yokoyama; Michael B Chancellor; William C de Groat; Naoki Yoshimura
Journal:  Neurourol Urodyn       Date:  2010-03       Impact factor: 2.696

Review 9.  Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal.

Authors:  Joop P van de Merwe; Jørgen Nordling; Pierre Bouchelouche; Kirsten Bouchelouche; Mauro Cervigni; L Kurosch Daha; Suzy Elneil; Magnus Fall; Gero Hohlbrugger; Paul Irwin; Svend Mortensen; Arndt van Ophoven; John L Osborne; Ralph Peeker; Benedikte Richter; Claus Riedl; Jukka Sairanen; Martina Tinzl; Jean-Jacques Wyndaele
Journal:  Eur Urol       Date:  2007-09-20       Impact factor: 20.096

10.  Clinical guidelines for interstitial cystitis and hypersensitive bladder updated in 2015.

Authors:  Yukio Homma; Tomohiro Ueda; Hikaru Tomoe; Alex Tl Lin; Hann-Chorng Kuo; Ming-Huei Lee; Seung-June Oh; Joon Chul Kim; Kyu-Sung Lee
Journal:  Int J Urol       Date:  2016-05-24       Impact factor: 3.369

View more
  7 in total

1.  Bone marrow mesenchymal stem cells therapy on bilateral pelvic nerve crush-induced voiding dysfunction in rats.

Authors:  Zhou Shen; Qingyu Ge; Deyun Shen; Kaiguo Xia; Jun Xiao
Journal:  Int Urogynecol J       Date:  2022-04-22       Impact factor: 1.932

2.  Effects of human Muse cells on bladder inflammation, overactivity, and nociception in a chemically induced Hunner-type interstitial cystitis-like rat model.

Authors:  Akira Furuta; Yasumasa Kuroda; Tokunori Yamamoto; Shin Egawa; Mari Dezawa; Naoki Yoshimura
Journal:  Int Urogynecol J       Date:  2022-03-25       Impact factor: 1.932

Review 3.  The role of bladder instillation in the treatment of bladder pain syndrome: Is intravesical treatment an effective option for patients with bladder pain as well as LUTS?

Authors:  Giuseppe Alessandro Digesu; Visha Tailor; Alka A Bhide; Vik Khullar
Journal:  Int Urogynecol J       Date:  2020-05-01       Impact factor: 2.894

4.  Possible role of intravenous administration of mesenchymal stem cells to alleviate interstitial cystitis/bladder pain syndrome in a Toll-like receptor-7 agonist-induced experimental animal model in rat.

Authors:  Hidetoshi Tabata; Masanori Sasaki; Yuko Kataoka-Sasaki; Nobuo Shinkai; Koji Ichihara; Naoya Masumori; Jeffery D Kocsis; Osamu Honmou
Journal:  BMC Urol       Date:  2021-11-13       Impact factor: 2.264

5.  Improved Urothelial Cell Proliferation, Cytoskeleton and Barrier Function Protein Expression in the Patients With Interstitial Cystitis/Bladder Pain Syndrome After Intravesical Platelet-Rich Plasma Injection.

Authors:  Jia-Fong Jhang; Yuan-Hong Jiang; Yung-Hsiang Hsu; Han-Chen Ho; Lori A Birder; Teng-Yi Lin; Hann-Chorng Kuo
Journal:  Int Neurourol J       Date:  2022-01-20       Impact factor: 2.835

6.  Effect of the neuropathic pain receptor P2X3 on bladder function induced by intraperitoneal injection of cyclophosphamide (CYP) in interstitial cystitis rats.

Authors:  Lei Pang; Jinkai Shao; Xiaodong Wen; Dong Liu; Zhijia Zhang; Weibing Shuang
Journal:  Transl Androl Urol       Date:  2022-03

Review 7.  Roles of mesenchymal stem cells and exosomes in interstitial cystitis/bladder pain syndrome.

Authors:  Chao Wen; Liping Xie; Chenxia Hu
Journal:  J Cell Mol Med       Date:  2021-12-24       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.